Related Experiment Video
Updated: Mar 17, 2026
07:25
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
6.2K
New Treatment Guidelines for Sjögren's Disease.
Frederick B Vivino1, Steven E Carsons2, Gary Foulks3
1Division of Rheumatology, Penn Presbyterian Medical Center, Penn Sjögren's Center, Penn Medicine University City, University of Pennsylvania, 3737 Market Street, Philadelphia, PA 19104, USA.
Rheumatic Diseases Clinics of North America
|July 20, 2016
Summary
The Sjögren's Syndrome Foundation created the first US clinical practice guidelines for Sjögren's disease management. These guidelines aim to standardize care, inform insurance, and identify research needs for this chronic autoimmune condition.
Area of Science:
- Rheumatology
- Immunology
- Clinical Practice Guidelines
Background:
- Sjögren's disease presents a significant burden, impacting quality of life and increasing healthcare expenses.
- Existing management strategies for Sjögren's disease manifestations lack standardized guidelines in the US.
- The Sjögren's Syndrome Foundation recognized the need for evidence-based clinical practice guidelines.
Purpose of the Study:
- To establish the first US clinical practice guidelines for managing Sjögren's disease.
- To address oral, ocular, and rheumatologic/systemic manifestations of Sjögren's disease.
- To improve the quality and consistency of care for patients with Sjögren's disease.
Main Methods:
- Development of guidelines by the Sjögren's Syndrome Foundation.
- Review of guideline recommendations by a consensus expert panel.
- Application of a modified Delphi process for expert review.
Main Results:
- The first US clinical practice guidelines for Sjögren's disease have been developed.
- Recommendations cover oral, ocular, and systemic manifestations.
- A consensus expert panel validated the guidelines using a modified Delphi process.
Conclusions:
- The developed guidelines are expected to enhance care quality and consistency for Sjögren's disease in the US.
- These guidelines will serve as a reference for insurance reimbursement decisions.
- The initiative identifies critical areas for future research in Sjögren's disease management.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:20Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
01:26Nephrotic Syndrome II : Assessment and Medical Management
295
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
295
01:28Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
01:24Nephrotic Syndrome III : Nursing Management
418
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
418
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
649
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
649